- Produce biotherapeutic proteins by using our own eukaryotic microalgae cell lines.
- Produce 3rd generation recombinant immunotoxins (RITs) in microalgal cells.
- Develop new biopharmaceuticals through novel proprietary vectoring systems which require no parenteral injection or refrigerated storage.
- Drive the innovation of biodrugs for oral & mucosal delivery and controlled release, apply it to antimicrobial (AMPs), antivirals (AViPs) and vaccines peptides, and further to glycoproteins and monoclonal antibodies.
We manufacture products using an assemblage of established technologies (fermenters, photobioreactors), in industrial quantities and at reduced cost, in accordance with the pharmaceutical industry quality practices.
Our industrial platform will be accessible to all global biopharmaceuticals producers.